drugset / Trial / NCT06257316

Appropriate Dosage of Vasopressor in Neonates and Infants

NCT06257316

Phase 4 Not yet recruiting 132 enrolled Seoul National University Hospital
RandomizedSequentialQuadruple-blindTreatment

Summary

In this study, the investigators will evaluate cerebral blood flow before and after drug infusion using ultrasound to suggest blood pressure criteria and dosage of ephedrine, a vasopressor, to maintain adequate cerebral blood flow in neonates and infants undergoing surgery and anesthesia.

Timeline

Start
2024-02-15
Primary completion
2027-02-28
Completion
2028-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ephedrine Small molecule 0.1 mg/kg Intravenous
Comparator Ephedrine Small molecule 0.2 mg/kg Intravenous
Comparator Ephedrine Small molecule 0.3 mg/kg Intravenous
Comparator Ephedrine Small molecule 0.5 mg/kg Intravenous
Comparator Ephedrine Small molecule 1 mg/kg Intravenous
Comparator Ephedrine Small molecule 1.2 mg/kg Intravenous

Indications